Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.150
+0.040 (3.60%)
At close: May 27, 2026, 4:00 PM EDT
1.160
+0.010 (0.87%)
After-hours: May 27, 2026, 6:28 PM EDT
Humacyte Employees
Humacyte had 184 employees as of December 31, 2025. The number of employees decreased by 36 or -16.36% compared to the previous year.
Employees
184
Change (1Y)
-36
Growth (1Y)
-16.36%
Revenue / Employee
$10,957
Profits / Employee
-$517,484
Market Cap
255.32M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 184 | -36 | -16.36% | 184 | 0 |
| Dec 31, 2024 | 220 | 35 | 18.92% | 218 | 2 |
| Dec 31, 2023 | 185 | 21 | 12.80% | 183 | 2 |
| Dec 31, 2022 | 164 | 18 | 12.33% | 164 | 0 |
| Dec 31, 2021 | 146 | - | - | 145 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Fate Therapeutics | 161 |
| LENZ Therapeutics | 152 |
| Entrada Therapeutics | 152 |
| Codexis | 146 |
| Adagene | 128 |
| Foghorn Therapeutics | 106 |
| Alector | 103 |
| Orchestra BioMed Holdings | 86 |
HUMA News
- 1 day ago - Humacyte announces presentation at VASA meeting on self-repair ATEV - TheFly
- 1 day ago - Humacyte Announces Presentation at VASA Meeting of Research Highlighting Self-Repair of ATEV After Cannulation for Dialysis Access - GlobeNewsWire
- 7 days ago - Humacyte reports Symvess under contract with Strategic Acquisition Center of VA - TheFly
- 7 days ago - Humacyte Announces Symvess® is Now Under Contract with the Strategic Acquisition Center (SAC) of the U.S. Department of Veterans Affairs - GlobeNewsWire
- 13 days ago - Humacyte price target raised to $1.50 from $1 at TD Cowen - TheFly
- 14 days ago - Humacyte Q1 Earnings Call Highlights - MarketBeat
- 14 days ago - Humacyte reports Q1 EPS (9c), consensus (12c) - TheFly
- 14 days ago - Humacyte Earnings Call Transcript: Q1 2026 - Transcripts